SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novartis Vaccines & Diagnostics, Inc. Signs Agreement With ProMetic BioSciences, Inc. To Develop An Affinity Ligand For Vaccine Purification